The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open both to previous contributors, for the update of these patients, and the entry of new patients. A key feature of the REDCap system is the capability to view and download all your data in one click. Subprojects focusing on one scientific question may be developed within the system, that will also contribute to the global database.
Please register at THIS LINK once the Data Transfer Agreement (available HERE) is signed with your institution, you will be able to access your patients and enter new patients. Guidelines on how to use the REDCap are available, and if needed, we can organize training sessions.
We expect to launch a call for application by end of 2024 to start analyzing the data. The call will be open only to contributors to the database.
TARGETTHYM-1 is the first sub-project based on the ITMIG prospective database infrastructure. Led by the Biology Working Group, the study aims at collecting data from patients with thymic malignancies who received targeted therapies – excluding antiangiogenic agents and immunotherapy- for advanced disease. We will collect molecular alterations, if any, identified at genomic profiling.
The project is open: to participate, please contact us!
Nicolas Girard (Database Committee Chair)
Paulette Salamoun Feghali (Database Manager)
Kind regards,
Nicolas Girard, ITMIG Database Committee Chair